Portfolio Allocation for ADR Stocks: ADR Investment Advice from Hong Kong Financial Advisors

On 1 January 2025, the Hong Kong Monetary Authority (HKMA) and the Securities and Futures Commission (SFC) jointly issued a revised circular on intermediaries’ sale and distribution of “complex” products, including American Depositary Receipts (ADRs) listed on US exchanges. This regulatory shift tightens suitability obligations for financial advisers recommending ADRs to Hong Kong retail investors. For the estimated 1.2 million Hong Kong adults holding US stocks directly or through MPF-linked investment platforms, the change means that portfolio allocation advice for ADR stocks must now satisfy stricter know-your-client and product due diligence standards. Separately, the SFC’s 2024 enforcement report recorded 12 cases involving mis-selling of offshore securities, with ADRs featuring in three of those actions. The following guide outlines what Hong Kong financial advisers must do under the new framework, and how investors can assess their own ADR exposure without crossing into unlicensed advice.

The Regulatory Framework for ADR Recommendations

The SFC’s “Complex Product” Designation

The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the Code) defines a “complex product” as one whose terms, features, or risks are not reasonably likely to be understood by a retail investor. Under the revised 2025 circular, the SFC explicitly includes ADRs that are not listed on a recognised stock exchange in Hong Kong or that carry embedded derivatives. The practical effect is this: a licensed adviser recommending a single-stock ADR, such as Alibaba Group Holding Limited (NYSE: BABA), to a retail client must first assess whether that ADR qualifies as complex. If it does, the adviser must provide a written explanation of the product’s risks and obtain the client’s signed acknowledgement before proceeding.

HKMA’s Suitability Obligations for Banks

The HKMA’s Supervisory Policy Manual module SA-2, last updated in December 2024, imposes parallel duties on authorised institutions. Banks selling ADRs through private banking or wealth management channels must conduct a product due diligence review that covers the ADR’s liquidity profile, the depositary bank’s reputation, and the underlying issuer’s home-market regulatory environment. For example, an ADR for a Chinese company listed on the New York Stock Exchange (NYSE) may face delisting risk under the US Holding Foreign Companies Accountable Act. The HKMA circular requires advisers to disclose this risk explicitly if the probability of delisting exceeds 5% based on publicly available data.

Portfolio Allocation Principles for ADR Stocks

Diversification Across Depositaries and Jurisdictions

Hong Kong financial advisers typically apply a 5–15% cap on ADR exposure within a retail client’s equity portfolio, depending on the client’s risk profile. The rationale is twofold. First, ADRs carry foreign exchange risk: the Hong Kong dollar is pegged to the US dollar, but the underlying shares of a Chinese ADR are denominated in renminbi, creating a cross-currency mismatch. Second, settlement risk differs. ADRs settle on a T+2 basis under US clearing house rules, whereas Hong Kong-listed stocks settle on T+1 under the Central Clearing and Settlement System. A 2023 HKMA study found that settlement failures for ADRs held by Hong Kong investors averaged 0.8% of trades, compared to 0.2% for local stocks.

Liquidity and Trading Volume Thresholds

The SFC’s 2024 thematic review of cross-border equity products recommended that advisers only recommend ADRs with an average daily trading volume (ADTV) of at least USD 10 million over the preceding six months. This threshold is not a statutory rule but is used by compliance departments as a safe harbour. For illustration, Tencent Holdings Limited’s ADR (OTC: TCEHY) had an ADTV of approximately USD 45 million in the first quarter of 2025, meeting this criterion. In contrast, a small-cap Chinese biotech ADR with an ADTV of USD 1.2 million would fail the test, and an adviser recommending it would need to document exceptional circumstances.

Practical Steps for Investors and Advisers

Step 1: Classify the ADR

An adviser must first determine whether the ADR is “complex” under the 2025 circular. The test is binary: if the ADR is listed on the NYSE or Nasdaq and the underlying shares are in a jurisdiction that the SFC does not recognise as having equivalent investor protection (e.g., China, Russia, or certain Middle Eastern markets), it is presumptively complex. If the ADR is sponsored and the depositary bank is a US or UK institution with a public credit rating of A- or above, the presumption may be rebutted by the adviser’s written analysis.

Step 2: Match the ADR to the Client’s Risk Profile

The HKMA’s revised suitability guidelines require a client’s risk tolerance score to be recalculated at least annually. For a client with a “moderate” risk profile, the adviser should allocate no more than 10% of the equity portion to ADRs, and no single ADR should exceed 3% of total portfolio value. These limits are derived from the HKMA’s sample portfolio construction templates, which are not binding but are used by major banks like HSBC and Standard Chartered.

Step 3: Document the Recommendation

All ADR recommendations must be recorded in a suitability letter that includes: (a) the ADR’s classification as complex or non-complex; (b) the specific risk factors identified, including delisting risk, currency risk, and settlement risk; (c) the client’s signed acknowledgement. Failure to document can result in disciplinary action. In 2024, the SFC fined a licensed representative HKD 150,000 for failing to maintain proper records for an ADR trade.

Key Risks Specific to ADRs Held by Hong Kong Investors

Delisting Risk Under US-China Tensions

The US Holding Foreign Companies Accountable Act (HFCAA) requires that foreign companies listed on US exchanges allow the Public Company Accounting Oversight Board (PCAOB) to inspect their audit workpapers. As of March 2025, 65 Chinese companies remain on the PCAOB’s non-compliance list, including several that issue ADRs. If a company is delisted, the ADR may convert into an over-the-counter (OTC) pink sheet security with severely reduced liquidity. The SFC’s 2024 guidance on cross-border delisting events advises that advisers must disclose this risk in writing if the client’s ADR exposure exceeds 5% of their net financial assets.

Dividend Taxation and Withholding

Dividends paid on ADRs are subject to US withholding tax at a rate of 30% for non-treaty countries. Hong Kong does not have a double taxation agreement with the US covering dividends, so Hong Kong resident investors face the full 30% rate. In contrast, dividends from Hong Kong-listed stocks are tax-free. The HKMA’s 2025 circular notes that this tax differential must be factored into any total-return projection for an ADR portfolio. An adviser who omits this disclosure may be found to have breached the Code’s requirement to present a “fair and balanced” view of the product.

Actionable Takeaways

1. Verify whether each ADR you hold or intend to buy is classified as “complex” under the SFC’s 2025 circular, as this triggers mandatory written risk disclosure and client acknowledgement.
2. Cap single-ADR exposure at 3% of total portfolio value for moderate-risk clients, and ensure the ADR’s average daily trading volume exceeds USD 10 million over the past six months.
3. Document every ADR recommendation in a suitability letter that includes delisting risk, currency risk, and settlement risk, and retain the record for at least seven years under the SFC’s record-keeping requirements.
4. Factor the 30% US withholding tax on ADR dividends into any total-return projection, and disclose this explicitly to the client.
5. If the ADR’s underlying issuer is on the PCAOB non-compliance list, provide a separate written warning that delisting could convert the security into an OTC pink sheet with near-zero liquidity.

This does not constitute legal advice. Consult a licensed financial adviser or solicitor for your specific investment situation.